EX-16.1 2 medmen_ex16-1.htm EXHIBIT 16.1

 

Exhibit 16.1

 

March 23, 2023

 

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 

Ladies and Gentlemen:

 

We have read the statements made by MedMen Enterprises Inc. included under Item 4.01(a) of its Form 8-K dated March 23, 2023. We agree with the statements concerning our Firm under Item 4.01(a). We are not in a position to agree or disagree with other statements contained therein.

 

Very truly yours,

 

/s/ MNP LLP 
MNP LLP 

 

Calgary, Canada